Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders

Recruiting Observational Study
Hereditary Spastic Paraplegia
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
2,000 (estimated)
Sponsor
Dr. Rebecca Schule · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of this study is to determine the clinical spectrum and natural progression of Hereditary Spastic Paraplegias (HSP) and related disorders in a prospective multicenter natural history study, identify digital, imaging and molecular biomarkers that can assist in diagnosis and therapy development and study the genetic etiology and molecular mechanisms of these diseases.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * One of the following: 1. Primary participant: Clinical or genetic diagnosis of HSP or a related disorder 2. Secondary participant: Unaffected family member (1st or 2nd degree relative) of primary participant (with the above-mentioned restrictions for special populations) …
Contacts

Rebecca Schüle, PD Dr.

+49 7071 29

rebecca.schuele-freyer@uni-tuebingen.de

CONTACT

Ludger Schöls, Prof. Dr.

+49 7071 29

ludger.schoels@uni-tuebingen.de

CONTACT